Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 433-240-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 13 SEP 1999 to 14 OCT 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 29 APR 1993
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 30 JUL 1996
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- According to Annex VII, Column 2 from Regulation (EC) No 1907/2006 (including amendments up to Commission regulation (EU) 2016/1688 of 20 September 2016) in vivo skin sensitisation studies that were carried out or initiated before 11 October 2016, and that meet the requirements set out in Article 13(3), first subparagraph, and Article 13(4) shall be considered appropriate to address standard information requirement for the endpoint skin sensitization. This applies for the guinea pig maximization test presented here.
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Test material form:
- solid: particulate/powder
- Details on test material:
- Batch: V.N0199.064
Expiry: 09.07.2001
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Ibm: GOHI; SPF quality (synonym: Himalayan spotted)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology & Animal Breeding Division, CH-4414-Füllinsdorf / Switzerland
- Females: nulliparous and non-pregnant
- Microbiological status of animals, when known: SPF animals
- Age at study initiation: 4-6 weeks
- Weight at study initiation: 322-335 g
- Housing: Individually in Makrolon type-4 cages with standard softwood bedding
- Diet: Pelleted standard Nafag Ecosan 845 25W4, batcg nos 64/99 and 79/99, guinea pig breeding / maintainance diet, ad libitum
- Water: Community tap water
- Acclimation period: 7 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +- 3
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: PEG 400
- Concentration / amount:
- 5%
- Day(s)/duration:
- Single application
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: PEG 400
- Concentration / amount:
- 25 %
- Day(s)/duration:
- 48 h
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challengeopen allclose all
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: PEG 400
- Concentration / amount:
- 5 %
- Day(s)/duration:
- 24 h
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #2
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: PEG 400
- Concentration / amount:
- 5%
- Day(s)/duration:
- 24 h
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 10 animals in test group, 5 animals in control group
- Details on study design:
- RANGE FINDING TESTS: yes
1) Intradermal pretest: Four intradermal injections (0.1 ml/site in 1:1 Freud´s complete adjuvant/physiological saline) in the neck of one guinea pig. One week later intradermal injections were made (0.1 ml/site in PEG 400) into the flank of the same animal at concentrations of 5, 3 and 1 %. Dermal reactions were assessed 24 h later.
2) Epidermal pretest: Four intradermal injections (0.1 ml/site in 1:1 Freud´s complete adjuvant/physiological saline) in the neck of two guinea pig. One week later, test substance was applied to the flanks of the animal (25, 15, 10 or 5 % in PEG 400). After 24 h substance was removed, 24 and 48 h after removal, reaction sited were assessed for erythema and oedema.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Three pairs of intradermal injections and an epidermal application on test day 8
- Exposure period: 3 weeks (1 week after the inreadermal injections epidermal applicationwas done. Two weeks after that, challenge was performed)
- Exposure group:
Three pairs of intradermal injections (0.1 ml/site) were made at the border of a 4 x 6 cm area in the clipped region as follows:
1) 1:1 (v/v) mixture of Freud´s Complete Adjuvant and physiological saline
2) Test item at 5% in PEG 400
3) Test item at 5 % in a 1.1 (v/v) mixture of freud´s Adjunat and physiological saline
-Control group:
Three pairs of intradermal injections (0.1 mL/site) were made at the border of a 4 x 6 cm area in the clipped region as follows:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) PEG 400
3) 1:1 (w/w) mixture of PEG 400 in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
- Site: scapular region
- Duration: single intradermal injection, occlusive dressing from epidermal application was left for 48 h.
- Control animals were not treated with the test item
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: day 22, two weeks after epidermal induction
- Exposure period: 24 h
- Site: flank (right flank treated with PEG 400, left flank treated with 5% test substance in PEG 400)
- Concentrations: 5 %
- Evaluation (hr after challenge): 24 and 48 h after removal, reaction sited were assessed for erythema and oedema.
- Control animals were treated with the test item as well.
Reading and Scoring:
The scoring system was performed by visual scoring of erythema, oedema and other clinical changes of skin conditions. They were assessed using the following Magnusson and Kligman gradng scale:
0 = no visible change
1 = discrete or patchy erytheman
2 = moderate and confluent erythema
3 = intense erythema and swelling - Positive control substance(s):
- yes
- Remarks:
- 2-mercaptobenzothiazole (analysed in a separate experiment)
Results and discussion
- Positive control results:
- 90% (24 h reading) and 100% (48 h reading) of treated animals were observed with very slight to moderate/severe erythematous reactions.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No signs of systemic toxicity were observed in the animals.
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No signs of systemic toxicity were observed in the animals.
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No signs of systemic toxicity were observed
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No signs of systemic toxicity were observed
- Remarks on result:
- no indication of skin sensitisation
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Tested in this study according to OECD test guideline no. 406 and GLP conditions the test item was not a skin sensitiser.
- Executive summary:
Testing for sensitising properties of the test item was performed in female guinea pigs according to the adjuvant sensitisation test by Magnusson and Kligman (Guinea pig Maximisation Test) according to OECD TG 406 and under GLP conditions. Intradermal induction was performed using 5% test item in PEG 400 or in a mixture of Freund's Adjuvant and physiological saline (1:1 (v/v)) or PEG 400 alone. Epidermal induction was carried out with 25 % test item in PEG 400.
Using 5% test item in PEG 400 for the challenge treatment resulted in a 0 % incidence of animals with skin reactions at the 24 and 48 hour reading in both the test group as well as the control group.
The positive control from the test lab showed distinctive positive results under the conditions applied in the lab (up to 100% of animals with positive skin reactions weras the control animals showed no skin reactions).
Under the conditions of the test, the test item was not a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.